Cited by 142Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

Van Laere, Koen, Goffin, Karolien, Casteels, Cindy, Dupont, Patrick, Mortelmans, Luc, de Hoon, Jan, Bormans, Guy·2008·NeuroImage

DOI 10.1016/j.neuroimage.2007.10.053

Open this paper in CoChat — free account

Abstract

The endocannabinoid system (ECS) is implicated as a regulator of homeostasis of several cerebral functions and is a novel target for drug treatment of neuropyschiatric disorders. So far, the cerebral cannabinoid-type 1 receptor (CB1R) has only been studied using in vitro, animal model, electrophysiological and post-mortem data. We have used positron emission tomography (PET) using a high-affinity, subtype-selective radioligand, [(18)F]MK-9470, to assess the in vivo cerebral CB1R distribution and its variation with healthy aging and gender. Fifty healthy volunteers (25 M/25 F, 18-69 years) underwent [(18)F]MK-9470 PET. Parametric [(18)F]MK-9470 binding maps were constructed, corrected for partial volume effects and analyzed using statistical parametric mapping in a combined categorical (gender) and covariate (age) design. We found that [(18)F]MK-9470 binding to CB1R increased with aging but only in women (p(FWE)<0.05, corrected for multiple comparisons); this was most pronounced in the basal ganglia, lateral temporal cortex and limbic system, especially in the hippocampus. Men showed higher [(18)F]MK-9470 binding then women (p<0.001, uncorrected), in clusters of the limbic system and cortico-striato-thalamic-cortical circuit. Region-dependent and gender-related upregulation of [(18)F]MK-9470 binding with aging is in line with ex vivo findings in rodent studies and may be associated with a changing homeostatic capacity or compensation mechanisms in the ECS that is modulated by sex hormones. In vivo PET of the CB1R will likely improve our understanding of the ECS in several neurological and psychiatric disorders.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2007.10.053

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients
Pi-Sunyer, X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & for the RIO-North America Study Group (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,227
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052

Show all 53 references

Sorted by citations

Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Hermanns‐Clausen, M., Kneisel, S., Szabó, B., & Auwärter, V. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04078.x · Cited by 478
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study
Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Cooper, Z. D., & Craft, R. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.140 · Cited by 369
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences
Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 330
Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data
Greve, D. N., Svarer, C., Fisher, P. M., Feng, L., Hansen, A. E., Baare, W., Rosen, B., Fischl, B., & Knudsen, G. M. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.12.021 · Cited by 264
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brašić, J. R., Guevara, M. C., Ye, W., Dannals, R. F., Ravert, H. T., Nandi, A., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.034 · Cited by 204
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex
Rubino, T., Prini, P., Piscitelli, F., Zamberletti, E., Trusel, M., Melis, M., Sagheddu, C., Ligresti, A., Tonini, R., Marzo, V. D., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.015 · Cited by 201
Functional consequences of marijuana use in adolescents
Jacobus, J., Bava, S., Cohen‐Zion, M., Mahmood, O. M., & Tapert, S. F. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.001 · Cited by 185
A Gender Perspective of Addictive Disorders
Fonseca, F., Robles-Martínez, M., Tirado-Muñoz, J., Alías-Ferri, M., Mestre-Pintó, J. I., Coratu, A. M., & Torrens, M. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00357-9 · Cited by 192
IMAGING STUDY: Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects
Lisdahl, K. M., McQueeny, T. M., Nagel, B. J., Hanson, K. L., Yang, T. T., & Tapert, S. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00166.x · Cited by 166
The endocannabinoid system in normal and pathological brain ageing
Bilkei‐Gorzó, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0388 · Cited by 161
Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
Schier, A. R. D. M., Ribeiro, N. D. C. R., Coutinho, D. C. O., Machado, S. E. D. C., Arias-Carrión, Ó., Crippa, J. A. S., Zuardi, A. W., Nardi, A. E., & Silva, A. R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140612114838 · Cited by 160
[18 F ] MK ‐9470 PET measurement of cannabinoid CB 1 receptor availability in chronic cannabis users
Ceccarini, J., Kuepper, R., Kemels, D., van Os, J., Henquet, C., & Laere, K. V. (2013) · Addiction Biology · doi:10.1111/adb.12116 · Cited by 149
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing to Drug Addiction: Effect of Ovarian Hormones
Castelli, M. P., Fadda, P., Casu, A., Spano, M. S., Casti, A., Fratta, W., & Fattore, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990430 · Cited by 148
Imaging the Cannabinoid CB1 Receptor in Humans with [ 11 C] OMAR: Assessment of Kinetic Analysis Methods, Test–Retest Reproducibility, and Gender Differences
Normandin, M. D., Zheng, M., Lin, K., Mason, N. S., Lin, S.-F., Ropchan, J. R., Labaree, D. C., Henry, S. E., Williams, W. A., Carson, R. E., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.46 · Cited by 145
Sex differences and the endocannabinoid system in pain
Blanton, H. L., Barnes, R. C., McHann, M. C., Bilbrey, J. A., Wilkerson, J. L., & Guindon, J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173107 · Cited by 151
Abnormal cerebellar morphometry in abstinent adolescent marijuana users
Lisdahl, K. M., Nagel, B. J., & Tapert, S. F. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.12.004 · Cited by 141
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
Laere, K. V., Casteels, C., Dhollander, I., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077156 · Cited by 122
Self-citation
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
Laere, K. V., Casteels, C., Lunskens, S., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.009 · Cited by 120
Self-citation
Mechanisms Underlying Sex Differences in Cannabis Use
Calakos, K. C., Bhatt, S., Foster, D. W., & Cosgrove, K. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0174-7 · Cited by 133
Sex difference in brain CB1 receptor availability in man
Laurikainen, H., Tuominen, L. J., Tikka, M., Merisaari, H., Armio, R.-L., Sormunen, E., Borgan, F., Veronese, M., Howes, O. D., Haaparanta‐Solin, M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.10.013 · Cited by 125
Changes in Cerebral CB1Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence
Ceccarini, J., Hompes, T., Verhaeghen, A., Casteels, C., Peuskens, H., Bormans, G., Claes, S., & Van Laere, K. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0849-13.2014 · Cited by 111
Self-citation
Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
Rubino, T., & Parolaro, D. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00064 · Cited by 106
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
Ceccarini, J., Binder, M. D., van Winkel, R., Peuskens, J., Bormans, G. M., Kranaster, L., Enning, F., Koethe, D., Leweke, F. M., & Laere, K. V. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.052 · Cited by 108
Self-citation
Towards a neurocircuitry in anorexia nervosa: Evidence from functional neuroimaging studies
van Kuyck, K., Gérard, N., Laere, K. V., Casteels, C., Pieters, G., Gabriëls, L. A., & Nuttin, B. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.04.005 · Cited by 106
Self-citation
Gi/o-Protein Coupled Receptors in the Aging Brain
de Oliveira, P. G., Ramos, M. L., Amaro, A. J. M., Dias, R. A., & Vieira, S. I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00089 · Cited by 111
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
Terry, G. E., Liow, J., Zoghbi, S. S., Hirvonen, J., Farris, A. G., Lerner, A., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.059 · Cited by 106
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
Morgan, C. J. A., Freeman, T. P., Powell, J. F., & Curran, H. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.219 · Cited by 101
Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands
Terry, G. E., Hirvonen, J., Liow, J., Zoghbi, S. S., Gladding, R. L., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., Morse, C. L., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067074 · Cited by 101
The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 99
Cannabinoids as anticancer therapeutic agents
Kovalchuk, O., & Kovalchuk, I. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1742952 · Cited by 96
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
Goffin, K. E., Paesschen, W. V., & Laere, K. V. (2011) · Brain · doi:10.1093/brain/awq385 · Cited by 88
Self-citation
Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour
Keeney, B. K., Raichlen, D. A., Meek, T. H., Wijeratne, R. S., Middleton, K. M., Gerdeman, G. L., & Garland, T. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32831c3b6b · Cited by 86
Endocannabinoids, cannabinoids and the regulation of anxiety
Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 91
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Wright, M., Ciano, P. D., & Brands, B. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0052 · Cited by 87
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence
Neumeister, A., Normandin, M. D., Murrough, J. W., Henry, S. E., Bailey, C. R., Luckenbaugh, D. A., Tuit, K. L., Zheng, M., Galatzer‐Levy, I. R., Sinha, R., et al. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01815.x · Cited by 73
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
Evens, N., Vandeputte, C., Coolen, C., Janssen, P., Sciot, R., Baekelandt, V., Verbruggen, A., Debyser, Z., Laere, K. V., & Bormans, G. M. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.09.005 · Cited by 73
Self-citation
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 72
In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
Ahmad, R. U., Goffin, K. E., den Stock, J. V., Winter, F. D., Cleeren, E., Bormans, G. M., Tournoy, J., Persoons, P., Laere, K. V., & Vandenbulcke, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.002 · Cited by 70
Self-citation
Use of Cannabis and Cannabinoids for Treatment of Cancer
Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022) · Cancers · doi:10.3390/cancers14205142 · Cited by 70
Relationship of Type 1 Cannabinoid Receptor Availability in the Human Brain to Novelty-Seeking Temperament
Laere, K. V., Goffin, K. E., Bormans, G. M., Casteels, C., Mortelmans, L., Hoon, J. N. J. M. D., Grachev, I. D., Vandenbulcke, M., & Pieters, G. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.530 · Cited by 67
Self-citation
Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder
Ney, L. J., Matthews, A. J., Bruno, R., & Felmingham, K. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.006 · Cited by 70
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Hou, L., Rong, J., Haider, A., Ogasawara, D., Varlow, C., Schafroth, M. A., Mu, L., Gan, J., Xu, H., Fowler, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01459 · Cited by 63
Advancing the science on cannabis concentrates and behavioural health
Bidwell, L. C., Martin‐Willett, R., & Karoly, H. C. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13281 · Cited by 60
Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders
Virdee, K., Cumming, P. D., Caprioli, D., Jupp, B., Rominger, A., Aigbirhio, F. I., Fryer, T. D., Riss, P. J., & Dalley, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.009 · Cited by 61
Acute effects of partial CB1 receptor agonists on cognition – A meta-analysis of human studies
Zhornitsky, S., Pelletier, J., Assaf, R., Giroux, S., Li, C.-S. R., & Potvin, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110063 · Cited by 54
Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
Bohorquez, S. M. S., Hamill, T. G., Goffin, K. E., Lepeleire, I. D., Bormans, G. M., Burns, H. D., & Laere, K. V. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1340-5 · Cited by 52
Self-citation
Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations
Nia, A. B., Mann, C. L., Kaur, H., & Ranganathan, M. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0167-4 · Cited by 51
Radiolabeling andin vitro/in vivoevaluation of N‐(1‐adamantyl)‐8‐methoxy‐4‐oxo‐1‐phenyl‐1,4‐dihydroquinoline‐3‐carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Mu, L., Bieri, D., Slavik, R., Drandarov, K., Herde, A. M., Čermak, S., Weber, M., Schibli, R., Krämer, S. D., & Ametamey, S. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12354 · Cited by 50
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
Ly, H. G., Ceccarini, J., Weltens, N., Bormans, G., van Laere, K., Tack, J., & van Oudenhove, L. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000375454 · Cited by 44
Self-citation
Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI
Goffin, K. E., Paesschen, W. V., Dupont, P. J., Baete, K., Palmini, A., Nuyts, J. L., & Laere, K. V. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1405-5 · Cited by 48
Self-citation
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [18F]MK-9470 PET study
Ceccarini, J., Weltens, N., Ly, H. G., Tack, J. F., Oudenhove, L. V., & Laere, K. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.118 · Cited by 45
A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis
Jacobson, M. R., Watts, J. J., Boileau, I., Tong, J., & Mizrahi, R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.014 · Cited by 45
Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
Colom, M., Vidal, B., & Zimmer, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00255 · Cited by 47
The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity
Struik, D., Sanna, F., & Fattore, L. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00249 · Cited by 44
Aging circadian rhythms and cannabinoids
Hodges, E. L., & Ashpole, N. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.008 · Cited by 44
Effects of cannabis exposure in the prenatal and adolescent periods: Preclinical and clinical studies in both sexes
Tirado-Muñoz, J., López-Rodríguez, A. B., Fonseca, F., Farré, M., Torrens, M., & Viveros, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100841 · Cited by 45
Comparison of Cannabinoid CB1Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470
Verdurand, M., Nguyen, V., Stark, D., Zahra, D., Grégoire, M., Greguric, I. D., & Zavitsanou, K. (2011) · International Journal of Molecular Imaging · doi:10.1155/2011/548123 · Cited by 41
THC, CBD, and Anxiety: a Review of Recent Findings on the Anxiolytic and Anxiogenic Effects of Cannabis’ Primary Cannabinoids
Lichenstein, S. D. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00450-7 · Cited by 38
PET imaging in multiple sclerosis
Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 40
Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety
Murkar, A., Koninck, J. D., & Merali, Z. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.002 · Cited by 35
Exogenous and Endogenous Cannabinoids Suppress Inhibitory Neurotransmission in the Human Neocortex
Kovacs, F. E., Knop, T., Urbanski, M. J., Freiman, I., Freiman, T. M., Feuerstein, T. J., Zentner, J., & Szabó, B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.262 · Cited by 34
Tactics for preclinical validation of receptor-binding radiotracers
Lever, S. Z., Fan, K.-H., & Lever, J. R. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.08.015 · Cited by 33
Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood
Pushkin, A. N., Dukes, A. J., Lallai, V., Torres-Mendoza, A., Fowler, J. P., Chen, E., & Fowler, C. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211346 · Cited by 31
Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
Ceccarini, J., Casteels, C., Ahmad, R. U., Crabbé, M., de Vliet, L. V., Vanhaute, H., Vandenbulcke, M., Vandenberghe, W., & Laere, K. V. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04445-x · Cited by 31
Self-citation
Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review
Hudson, A., & Hudson, P. (2020) · Clinical Gerontologist · doi:10.1080/07317115.2020.1808134 · Cited by 34
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history
Dow-Edwards, D. L., Frank, A., Wade, D., Weedon, J., & Izenwasser, S. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.09.004 · Cited by 33
Enhancing effects of acute exposure to cannabis smoke on working memory performance
Blaes, S. L., Orsini, C. A., Holik, H., Stubbs, T., Ferguson, S. N., Heshmati, S. C., Bruner, M. M., Wall, S. C., Febo, M., Bruijnzeel, A. W., et al. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.12.001 · Cited by 26
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients
der Schueren, B. V., Laere, K. V., Gérard, N., Bormans, G. M., & Hoon, J. N. J. M. D. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02030.x · Cited by 29
Self-citation
Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
Casteels, C., Koole, M. J. B., Celen, S., Bormans, G. M., & Laere, K. V. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2163-3 · Cited by 26
Self-citation
Lipid endocannabinoids in energy metabolism, stress and developmental programming
de Almeida, M. M., Dias-Rocha, C. P., Calviño, C., & Trevenzoli, I. H. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111522 · Cited by 27
Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review
Arenas, L. P., Díaz, I., & Arenas, M. C. (2022) · Brain Sciences · doi:10.3390/brainsci12030388 · Cited by 28
Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands
Ginsburg, B. C., & Hensler, J. G. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173339 · Cited by 25
[18F]FMPEP-d2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease
Helin, J. S., Lopez‐Picon, F. R., Kirjavainen, A. K., Pihlaja, R., Snellman, A., Ishizu, T., Löyttyniemi, E., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.013 · Cited by 28
Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470
Gérard, N., Ceccarini, J., Bormans, G. M., Vanbilloen, B., Casteels, C., Goffin, K. E., Bosier, B., Lambert, D. M., & Laere, K. V. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9340-2 · Cited by 25
Self-citation
Regulation of cannabinoid CB1 and CB2 receptors, neuroprotective mTOR and pro-apoptotic JNK1/2 kinases in postmortem prefrontal cortex of subjects with major depressive disorder
Salort, G., Hernández‐Hernández, E., García-Fuster, M. J., & Garcı́a-Sevilla, J. A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.074 · Cited by 21
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
Mu, L., Slavik, R., Herde, A. M., Popaj, K., Čermak, S., Weber, M., Schibli, R., Krämer, S. D., & Ametamey, S. M. (2014) · Pharmaceuticals · doi:10.3390/ph7030339 · Cited by 20
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21
Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET
Radhakrishnan, R., Worhunsky, P. D., Zheng, M., Najafzadeh, S., Gallezot, J., Planeta, B. M., Henry, S. E., Nabulsi, N., Ranganathan, M., Skosnik, P. D., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119674 · Cited by 20
Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults
Ertl, N., Lawn, W., Mokrysz, C., Freeman, T. P., Alnagger, N., Borissova, A., Fernandez‐Vinson, N., Lees, R., Ofori, S., Petrilli, K., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231189441 · Cited by 18
Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity
Manca, C., Carta, G., Murru, E., Abolghasemi, A., Ansar, H., Errigo, A., Cani, P. D., Banni, S., & Pes, G. M. (2021) · GeroScience · doi:10.1007/s11357-021-00342-0 · Cited by 18
Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC)
Nia, A. B., Orejarena, M. J., Flynn, L. T., Luddy, C., D’Souza, D. C., Skosnik, P. D., Pittman, B. P., & Ranganathan, M. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06135-3 · Cited by 17
The circulating and central endocannabinoid system in obesity and weight loss
Mattelaer, N., der Schueren, B. V., Oudenhove, L. V., Weltens, N., & Vangoitsenhoven, R. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01553-z · Cited by 16
Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP
Lahdenpohja, S., Rajala, N., Helin, J. S., Haaparanta‐Solin, M., Solin, O. H., Lopez‐Picon, F. R., & Kirjavainen, A. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00313 · Cited by 17
Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review
Fuentes, J. J., Mayans, J., Guarro, M., Canosa, I., Mestre-Pintó, J. I., Fonseca, F., & Torrens, M. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05986-8 · Cited by 14
Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis
Bortolato, M., Bini, V., & Tambaro, S. (2010) · Pharmaceuticals · doi:10.3390/ph3092799 · Cited by 17
Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study
Aghaei, A. M., Spillane, L. U., Pittman, B. P., Flynn, L. T., Aquino, J. P. D., Nia, A. B., & Ranganathan, M. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06625-6 · Cited by 13
Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
Murray, C. J., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119552 · Cited by 12
Gender Differences in Cannabis Addiction and Dependence
Davis, C. A., & Fattore, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_12 · Cited by 12
PET Imaging of Endocannabinoid System
Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 11
Effects of cannabis smoke and oral Δ9THC on cognition in young adult and aged rats
Zequeira, S., Gazarov, E. A., Güvenli, A. A., Berthold, E. C., Senetra, A. S., Febo, M., Hiranita, T., McMahon, L. R., Sharma, A., McCurdy, C. R., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06754-6 · Cited by 10
Endocannabinoid System Biomarkers in Alzheimer's Disease
Ferreira, P. C. L., Bellaver, B., Povala, G., Brum, W. S., Tissot, C., Badji, A., Sloan, M. E., Benedet, A. L., Rosa‐Neto, P., Ashton, N. J., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0151 · Cited by 11
Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders
Royse, S. K., Lopresti, B. J., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15657 · Cited by 10
Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
Gräfe, E. L., Reid, H. M. O., Shkolnikov, I., Conway, K., Kit, A., Acosta, C., & Christie, B. R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101076 · Cited by 10
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brašić, J. R., Guevara, M. C., Nandi, A., Rahmim, A., Ming, J. E., & Cascella, N. G. (2010) · Journal of Nuclear Medicine · Cited by 10
Cannabinoids for the Treatment of Movement Disorders
Catlow, B. J., & Sanchez‐Ramos, J. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0370-5 · Cited by 8
Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study
Ceccarini, J., Koole, M. J. B., & Laere, K. V. (2022) · Addiction Biology · doi:10.1111/adb.13167 · Cited by 7
Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
Abdelmoneim, W. M., Ghandour, N., Fawzy, M., Mohammed, M. K., Ramadan, A. G., & Abdellah, N. Z. (2022) · Middle East Current Psychiatry · doi:10.1186/s43045-022-00188-y · Cited by 7
Correlations of the CNR1 Gene with Personality Traits in Women with Alcohol Use Disorder
Maciocha, F., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Ciechanowicz, A., & Boroń, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105174 · Cited by 6
How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Toward Cannabinoid-Induced Effects
Antinori, S., & Fattore, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_2 · Cited by 6

Authors: Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G.
Affiliations: Universitair Ziekenhuis Leuven (BE)
KU Leuven (BE)
ORCID: Goffin, Karolien
Casteels, Cindy
Dupont, Patrick
Bormans, Guy
Venue: NeuroImage
Publisher: Elsevier BV
Published: 2008-02
Volume: 39
Issue: 4
Pages: 1533-1541
ISSN: 1053-8119 (ISSN-L)
DOI: 10.1016/j.neuroimage.2007.10.053
OpenAlex: W2088851718
Cited by: 142
References: 53
Citations by year: 2026: 7 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 11 · 2013: 11 · 2012: 6
FWCI: 3.72
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroImage (publishedVersion)
PubMed (publishedVersion)
Lirias (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabinoid type 1 receptor, CB1R, endocannabinoid system, healthy aging, sex differences, positron emission tomography, hippocampus, basal ganglia, limbic system, sex hormones, receptor binding
MeSH terms: Adolescent, Adult, Aged, Aging, Brain, Brain Chemistry, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Pyridines, Reference Values, Sex Characteristics, Radiopharmaceuticals, Area Under Curve, Receptor, Cannabinoid, CB1, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks